ArticleEmerging infectious diseases2025
Extended-Spectrum β-Lactamase-Producing Enterobacterales in Municipal Wastewater Collections, Switzerland, 2019-2023.
Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrated Analyses of Longitudinal Trends of Antibiotic-Resistant Bacteria in Wastewater, Clinical Resistance Data, and Antibiotic Consumption in Switzerland.Environmental science & technology · 2026Article
- Plasmids of the multidrug-resistantMicrobiology spectrum · 2026Article
- Linking wet-lab and genomic approaches for reliable detection of carbapenemase-producingFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We quantified presumptive extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella, Enterobacter, Serratia, and Citrobacter group colonies from wastewater in Basel, Switzerland, across 3 years to represent before, during, and after the COVID-19 pandemic. Wastewater surveillance might be a noninvasive, sensitive, rapid, and cost-effective instrument for early detection and monitoring local epidemiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.